SGLT2 Inhibitors: A Novel Pharmacological Approach in Heart Failure Treatment?

Subject areas

This course counts toward the state boards and subject areas below.

Disclosure statements

Learning Objectives

Pharmacist

1. Explain the proposed mechanisms of action of SGLT2 inhibitors in reducing the risk of adverse heart failure outcomes
2. Examine the current evidence for SGLT2 inhibitors in HFrEF and HFpEF
3. Summarize the adverse effects associated with SGLT2 inhibitors

Pharmacy Technician

1. Review the proposed mechanisms of action of SGLT2 inhibitors in reducing the risk of adverse heart failure outcomes
2. Summarize the adverse effects associated with SGLT2 inhibitors

This activity was developed by AchieveCE free of any commercial support. Shyam Gelot, PharmD, BCPS, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose.

Peter A. Kreckel, RPh, planners for this activity, also have no relevant financial relationship(s) with ineligible companies to disclose. AchieveCE’s full accreditation list can be found on their accreditations page.

Take it Here

• This course reports to CE broker immediately upon completion.
• Complete all courses at your own pace online.
• Quality and enjoyable courses.
• Modern experience, accessible from any device.
• All courses affordably priced.

Learner Feedback